- Global Pharma News & Resources

Press Releases - 2023-01-24

Date Title Company
24-Jan-2023 AmerisourceBergen Announces Intent to Change Name to Cencora AmerisourceBergen
24-Jan-2023 Dentsu Appoints Greg Reilly as President, dentsu health Dentsu
24-Jan-2023 Velocity announces three leadership hires in Europe Velocity Clinical Research
24-Jan-2023 TIACA Appoints Eric Hartmann as Regional Representative – Latin America TIACA
24-Jan-2023 Panoramic Health Solidifies Position as Largest Physician-Led Participant in Medicare's Kidney Care Choices Model Newswire
24-Jan-2023 Aston University collaborates with biotechnology start-up to develop drugs to tackle lung disease Aston University
24-Jan-2023 Thermo Fisher Scientific Partners with AstraZeneca to Develop Solid Tissue and Blood-Based Companion Diagnostic Test for Tagrisso Thermo Fisher Scientific
24-Jan-2023 Edmund Optics®’ Samuel Sadoulet named as a 2023 SPIE Fellow Edmund Optics®
24-Jan-2023 Amolyt Pharma Announces Research Agreement and Licensing Option with XOMA Amolyt Pharma
24-Jan-2023 Experic Expands Analytical Laboratory Capabilities and Facilities Experic
24-Jan-2023 ABPI response to MHRA European Commission Decision Reliance Procedure (ECDRP) announcement ABPI
24-Jan-2023 Complexion Analysis System Market Size, Share, Growth Statistics 2023 to 2032 | insightSLICE insightSLICE
24-Jan-2023 Communicable Diseases Treatment Market Growth Statistics, Size Share, Regional Outlook 2023 to 2032 | insightSLICE insightSLICE
24-Jan-2023 Increasing number of spinal fusion surgeries is driving the sales of Bone Grafts and Substitutes Market | insightSLICE insightSLICE
24-Jan-2023 Electromyography Devices Market Size, Share, Growth Analysis Outlook 2023 to 2032 | insightSLICE insightSLICE
24-Jan-2023 Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022 Genmab
24-Jan-2023 finnCap Cavendish advises on the sale of Therapy Equipment Limited to ESAB Corporation finnCap Cavendish
24-Jan-2023 New imaging tool to understand inflammation Edinburgh Innovations
24-Jan-2023 Amber Therapeutics announces successful first-in-human implants of Amber-UI: an intelligent, closed-loop bioelectrical therapy for urge and mixed urinary incontinence Amber Therapeutics
24-Jan-2023 Medicines manufacturing has the potential to drive UK growth over the next 10 years Medicines Manufacturing Industry Partnership